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ABSTRACT
Cellgrowthandproliferationaretightlycontrolledvia
the regulation of the p53–MDM2 feedback loop in
response to various cellular stresses. In this study,
we identified a nucleolar protein called PAK1IP1
as another regulator of this loop. PAK1IP1 was
induced when cells were treated with chemicals
that disturb ribosome biogenesis. Overexpression
of PAK1IP1 inhibited cell proliferation by inducing
p53-dependent G1 cell-cycle arrest. PAK1IP1 bound
to MDM2 and inhibited its ability to ubiquitinate and
todegradep53,consequentlyleadingtotheaccumu-
lation of p53 levels. Interestingly, knockdown of
PAK1IP1 in cells also inhibited cell proliferation and
induced p53-dependent G1 arrest. Deficiency of
PAK1IP1 increased free ribosomal protein L5 and
L11 which were required for PAK1IP1 depletion-
induced p53 activation. Taken together, our results
reveal that PAK1IP1 is a new nucleolar protein that is
crucial for rRNA processing and plays a regulatory
role in cell proliferation via the p53–MDM2 loop.
INTRODUCTION
Cell growth and proliferation are two precisely controlled
and integrated processes throughout the whole life of an
organism. The maintenance of an appropriate cell number
in a well-functioning organ is dependent on the balance of
the rate at which cells are generated via proliferation and
eliminated by apoptosis (1). Cell proliferation is highly
regulated at each phase of the cell cycle, and the G1/S
checkpoint is one of the major cell-cycle transition
points. At the G1/S transition, a cell can decide its fate,
such as cell division, G1 arrest, quiescence, or differenti-
ation, in response to diverse signals (2,3). Any malfunc-
tions at this checkpoint, such as activation of an oncogene
or inactivation of a tumor suppressor gene, may lead to
abnormal cell proliferation and transformation, conse-
quently cancer development (4,5). One of the most import-
ant tumor suppressor genes is TP53, which is mutated in
>50% of all types of human cancers while the rest of
cancers are often associated with alterations of p53 modu-
lators that regulate p53 stability and activity. For
example, the mdm2 gene, which encodes a p53 suppressor
called MDM2, is upregulated in 7% of human cancers
which lack the mutation of p53 (6–8). In normal un-
stressed cells, p53 level is low mainly due to the regulation
by MDM2, which is transcriptionally stimulated by
p53 and functions as an E3 ubiquitin ligase to mediate
p53 ubiquitination and degradation through a feedback
mechanism (8–12).
Upon stress conditions, such as genotoxic, oncogenic
and nucleolar stresses, p53 is stabilized and activated
largely through the inhibition of MDM2, leading to
cell-cycle arrest, apoptosis, DNA repair or senescence
(13). In response to nucleolar stress, several nucleolar
proteins including nucleophosmin, nucleostemin, L5,
L11, L23 and S7 interact with MDM2 and inhibit its
activity, leading to p53 stabilization (14–21). Nucleolar/
ribosomal stress is induced by the perturbation of riboso-
mal biogenesis, such as the interference in rRNA synthe-
sis, processing and ribosome assembly (22,23). It has been
reported that the treatment of human cells with
ﬂuorouracil (5-FU) or actinomycin D (low doses), serum
starvation, disruption of nucleolar or ribosomal proteins
leads to ribosomal stress, and consequently, p53 activation
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al role in transmitting nucleolar stress signals to the
p53 pathway, coupling this pathway with ribosomal
biogenesis (25).
PAK1IP1, a PAK1-interacting protein (also called
hPIP1), was previously identiﬁed as a component in
highly puriﬁed nucleoli of human cells (26,27). This
protein contains ﬁve G protein b-like WD40 repeats and
shares high sequence homology with Mak11 in budding
yeast (28) and Skb15 in ﬁssion yeast (29). The two yeast
orthologs of PAK1IP1 are involved in 60S rRNA biogen-
esis and essential for cell viability (30,31). Our previous
study showed that PAK1IP1 is abundantly expressed in
most human tissues, and negatively regulates the activity
of PAK1 (27) which has been shown to regulate various
cellular activities, including cell proliferation, cell survival,
mitosis and transcription (32–35). Although we have
demonstrated that mouse Pak1ip1 can substitute Skb15
function in ﬁssion yeast, the cellular and biochemical func-
tions of PAK1IP1 in mammalian cells is poorly
understood.
In an attempt to address this issue, we identiﬁed new
functions of PAK1IP1 in regulating the cell cycle via the
p53–MDM2 pathway as described in this study. With a
functional nuclear/nucleolar localization signal sequence,
PAK1IP1 could localize in both the nucleoplasm and nu-
cleolus. Overexpression of PAK1IP1 stabilized p53
protein level and inhibited cell proliferation by inducing
G1 arrest. PAK1IP1 executed this cellular function by
interacting with MDM2 and inhibiting its activity
toward p53 ubiquitination and degradation. Knockdown
of PAK1IP1 by shRNA induced p53 activation through
enhancement of the binding of the ribosomal proteins L5
and L11 to MDM2 in human cancer cells. Therefore, these
results reveal a novel and critical role of PAK1IP1 in
cell-cycle regulation through the modulation of the p53–
MDM2 feedback loop.
MATERIALS AND METHODS
Cell cultures and transfection
Human HeLa, HEK293T, U2OS, Saos2, A549, H1299
cells were cultured in Dulbecco’s modiﬁed Eagle’s
medium (DMEM, Gibco, USA), supplemented with
10% fetal bovine serum (FBS), 100U each of penicillin
and streptomycin, in an air—5% CO2 atmosphere at
constant humidity. For transfection, plasmids or siRNA
were mixed with Lipofectamine 2000 reagent (Invitrogen
Inc.) in Opti-MEM (Gibco, USA) and incubated at room
temperature for 20min. The Lipofectamine 2000–DNA
complex was added to cells and mixed by gentle agitation.
Growth media containing 10% FBS were exchanged to
the cells 6h after transfection of the plasmids.
DNA construction
To generate a fusion protein of PAK1IP1 with enhanced
green ﬂuorescent protein (EGFP), the PAK1IP1 ORF was
subcloned into the XhoI and EcoRI (NEB) sites of the
pEGFP-C3, each mutant of PAK1IP1 sequence was
subclonedintopEGFP-vector,orsite-directedmutagenesis
PCR according to the QuikChange XL Site-Directed
Mutagenesis Kit (stratagene). The direct PCR Primers
used for constructs mentioned above are as follows:
pEGFP-C3-PAK1IP1: F-50 GGCTCGAGATGGAGCT
GGTCGCTGGTTGCTAC 30 and R-50 CAGAATTCCT
GCAGCCCTCAGGAGAC 30; pEGFP-N2-PAK1IP1-
WD40: F-50 TAAGAATTCATATGGAGCTGGTCGCT
GGTT30 andR-50 GTAGTCGACCAGGCTCCTTTTTG
CCAA 30; pEGFP-N2-PAK1IP1-dWD40: F-50 GGGGAA
TTCACGTGTCTTGGAGTGTGG 30 and R-50 GGGGT
CGACACTGCATTGTTTTTATTTTC 30.
The site-directed mutagenesis PCR primers used forcon-
structs mentioned above as follow: pEGFP-C3-PAK1IP1-
mNoLS1: F-50 GGCCTGATATCAACCGCAGCGGCA
GCAATGGTAGAAATGTTGGAAAAG 30 andR-50 CA
ACATTTCTACCATTGCTGCCGCTGCGGTTGATA
TCAGGCCACTTTC 30; pEGFP-C3-PAK1IP1-mNoLS2
: F-50 GGTAGAAATGTTGGAAGCGGCGGCAGCAA
AGAAGAAAATAAAAACAATGC 30 and R-50 TTATT
TTCTTCTTTGCTGCCGCCGCTTCCAACATTTCTA
CCATTTTCCTC 30; This construct used for all experi-
ments except where indicated, and pEGFP-C3-PAK1IP1-
mNoLS3 : F-50 AGAAGAGGAAAGCGGCGGCAATA
GCAACAATGCAGTGAATCACAG 30 and R-50 CACT
GCATTGTTGCTATTGCCGCCGCTTTCCTCTTCTT
TTCCAAC 30.
Immunoprecipitation and western blot
Binding of PAK1IP1 with human MDM2 in ﬁve-dish
(10cm) mammalian cells was examined by immunopre-
cipitaion and by western blot analysis, which were
performed as previously described (36). Antibodies
recognizing PAK1IP1 (#sc-101866, Santa Cruz, USA and
#ab67348, Abcam, UK), M2 Flag Antibody and anti-Flag
M2 afﬁnity beads (F1804 and A2220, Sigma, Germany)
p53 (DO1) and MDM2 (N-20) (#sc-126 and #sc-813,
Santa Cruz, CA, USA), p21 (Cell Signaling Technology,
MA, USA) were used in IP and WB analysis. Anti-L5 and
anti-L11 have been previously described previously (21).
The relative ratios of western blot signals were estimated
with the Image-Pro plus 6.0 software (Media Cybernetics).
Lentivirus-based PAK1IP1 overexpression and knockdown
For the overexpression of lentiviral constructs, the
lentivirus-based vector pLL3.7 was employed (37). The
fragments of GFP-PAK1IP1, GFP-PAK1IP1-dNLS
and GFP-PAK1IP1-mNoLS derived from pEGFP-
constructs and substituted the GFP sequence of pLL3.7
vector using the NheI and EcoRI. For the knockdown
constructs, we designed two shRNA oligos used the
promega shRNA Design software (http://www.promega.
com/siRNADesigner/program/default.asp), two shRNAs
(237–255, 884–902) were designed corresponding to
nuclear acids of ORF (open reading frame), and the se-
quences are below: shRNA1(884–902), Forward- 50 TGG
CTGACGTGTCTTGGAGTTTCAAGAGTGAGGTTC
TGTGCAGTCGGTTTTTTC 30 and Reverse- 50 ACCGA
CTGCACAGAACCTCAAAGTTCTCACTCCAAGAC
ACGTCAGCCAAAAAAGAGCT 30; shRNA2(237-255),
Farward-50 TGCATCACAGTGGTACAATATTCAAG
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construct used for all experiments except where indicated,
and Reverse- 50 ACGTAGTGTCACCATGTTATAAGT
TCTCTATAACATGGTGACACTACGAAAAAAGAG
CT 30; These oliognucleotides were annealed and ligated
into pLL3.7. Following DNA sequencing conﬁrmation,
the overexpression, knockdown or control construct, was
transiently co-transfected into 293T cells along with the
gag, env-expressing plasmids, Virus-containing super-
natants were collected and used to infect target cells.
Expression of wild-type and mutant PAK1IP1 was
determined by Inverted Fluorescence Microscope and
western blotting using antibody against PAK1IP1. The
target sequence of TP53 is obtained from Thermo
Scientiﬁc Dharmacon, and the target sequences for L5,
L11 and the control scrambled siRNA have been described
previously (17,38).
Cell proliferation and colony formation assays
For the cell growth curve assay, the infected cells were
seeded at 2 10
4 cells/well and grown in 24-well plates
for continual 1–7 days in triplicate. The cells were har-
vested and counted on the time point as indicated. For
cell viability assay, a modiﬁed MTT assay (Promega,
Madison, WI, USA) was used. 5000 infected cells were
plated into 96-well plates in triplicate for 3 days. The
20ml MTS was added according to manufacturer instruc-
tion. Absorbance was measured at 490nm using a
microplate reader and is directly proportional to the
number of viable cells in the cultures. For colony forma-
tion assay, the infected cells were sorted by FACS, and
1000 cells were plated into 6cm dish in triplicate. After
cells were cultured for 2–4 weeks, the cells were stained
with 0.4% crystal violet (dissolved in 95% ethanol). The
number of colonies, in triplicate wells were photographed
and counted to generate the histograms.
Cell-cycle analysis
To determination of cell-cycle distribution, the transfected
or infected cells were let grow to  30–40% conﬂucence.
The cells were treated with 2mM thymidine (Sigma) for
12h, and released into DMEM growth media for 10h,
then secondary thymidine block for 12h, ﬁnally release
cells into DMEM growth medium. The cells were har-
vested after release in the indicated time, then ﬁxed with
70% cold ethanol and stained with 50mg/ml propidium
iodide (Sigma, St Louis, MO, USA) followed with
RNase A (Sigma) treatment for 30min at room tempera-
ture. DNA content was analyzed by FACscan cell
analyzer (BD Biosciences, San Jose, CA, USA) equipped
with Cellquest software (BD Biosciences). The population
of cells in each phase was determined using ModFit LT
software (BD Biosciences).
Indirect immunoﬂuorescence
The transfected or infected cells were seeded onto glass
cover slips. Cells were washed with phosphate-buffered
saline, ﬁxed at room temperature using 4%
paraformaldehyde, followed by 0.5% Triton-X 100 in
phosphate-buffered saline for 15min at room temperature.
Cells were stained with indicated antibodies, followed by
FITC or TRITC-conjugated immunoglobulins. Nuclei
were counterstained with DAPI. The images were taken
by confocal laser scanning microscopy (CLSM; Leica
TCS SP5).
BrdU incorporation assays
Bromodeoxyuridine (BrdU) incorporation assays were
conducted as described previously (21). Tranfected cells
were incubated in the presence of 10mM BrdU (Sigma)
for 10h after starvation overnight. Cells were then ﬁxed
with 4% paraformaldehyde and treated with 2M HCl
containing 1% Triton X-100. The cells were stained with
monoclonal anti-BrdU (Sigma) antibody and then stained
with TRITC-conjugated goat anti-mouse antibodies and
DAPI. The red immunoﬂuorescence, indicating BrdU
staining, The total numbers of GFP-positive cells, as
well as BrdU-labeled cells, were counted in 5–10 different
ﬁelds of each well.
In vivo ubiquitylation assay
Human p53-null H1299 cells were transfected with
indicated plasmids. The cells were treated with 20mMo f
MG132 for 6h before they were harvested at 36h
post-transfection. In vivo ubiquitinlation assays were con-
ducted as described previously (21). In brief, 10% of the
total suspension was retained for total protein analysis.
The remaining cell fraction was lysed under denaturing
conditions with the 6M guanidinium–HCl buffer. Total
His-ubiquitin protein conjugates were puriﬁed by afﬁnity
chromatography using Ni
2+ NTA agarose beads and the
levels of ubiquitination were determined using anti-p53
antibody or anti-MDM2 antibody.
Sucrose gradient centrifugation
Sucrose gradient sedimentation of polysomes, and
analysis of the polysome and mRNP distribution of
proteins were carried out as previously described with
minor modiﬁcations (17). Brieﬂy, cells were incubated
with 50mg of cycloheximide/ml for 5min. The cells were
sonicated on ice using an ultrasonic processor equipped
with a microtip and sonication buffer containing 25mM
Tris–Cl, pH 7.5, 100mM KCl, 1mM NaF, 2mM EDTA,
0.05% (v/v) NP-40, 1mM DTT, 10ml/ml protease inhibi-
tor cocktail (Sigma), 50–100U/ml RNase inhibitor
(TaKaRa). Each supernatant was subjected to sedimenta-
tion centrifugation in a 10–50% sucrose gradient solution
containing 25mM Tris–HCl (pH 7.5), 2mM EDTA and
100mM KCl in a Beckman SW41 rotor at 37000rpm for
3h. Fourteen fractions were collected and the proteins
were concentrated using 20% trichloroacetic acid (TCA)
for western blotting.
RESULTS
PAK1IP1 is a nucleolar stress induced nucleolar protein
with nuclearoplasmic localization
It was recently reported that Mak11 and Skb15, the yeast
orthologs of PAK1IP1, play important roles in 60S
2236 Nucleic Acids Research, 2011,Vol.39, No. 6ribosome biogenesis (26,31), but the cellular and biochem-
ical functions of PAK1IP1 in mammalian cells remain
largely elusive. To understand the potential role of
PAK1IP1 in ribosomal stress response, we ﬁrst examined
the protein expression level of PAK1IP1 in response to
ribosomal stress using ﬂuorouracil (5-FU) or actinomycin
D (ActD). These two chemotherapeutic agents inhibit
ribosome biogenesis and trigger nucleolar stress, and sub-
sequently, lead to p53 stabilization and cell growth arrest
(15,39). As shown in Figure 1A, when HeLa cells were
treated with 5-FU for 18h, the protein level of
PAK1IP1 was signiﬁcantly upregulated with the
increasing amount of 5-FU in a dose-dependent fashion
(Figure 1A, left panel). As a positive control, the expres-
sion of p53 is also increased with the treatment of 5-FU
(Figure 1A, middle). Similarly, ActD also induced the
expression of PAK1IP1 protein in a dose-dependent
manner (Figure 1A, right panel). These results suggest
that PAK1IP1 is a ribosomal stress-induced protein and
could play an important role in ribosomal stress
responses.
The nucleolus plays an important role in ribosomal
stress response (23). We then examined the localization
of PAK1IP1 using immunoﬂuorescence staining. As
shown in Figure 1B, both endogenous and exogeneous
PAK1IP1 proteins exhibited diffuse nucleoplasmic distri-
bution with apparently nucleolar accumulation,
colocalizing with nucleophosmin (NPM1), the granular
component marker, and the high quality image was
shown in Supplementary Figure S1. Similar results were
also observed in U2OS and 293T cells (data not shown).
Thus, PAK1IP1 mainly resides in the nucleolus with
minor nucleoplasmic distribution.
To identify the nuclear and nucleolar localization signal
sequence(s) (NLS/NoLS) of PAK1IP1, we used the
LOCtree software (40) and identiﬁed three consensus
(R/K) (R/K) X (R/K) sequences in the C-terminus [from
371 to 389 amino-acid residues (KKRKMVEMLE
KKRKKKKIK)] of PAK1IP1 as potential NLS/NoLSs
(41). To validate these sites, we generated a set of deletion
mutations of PAK1IP1 (abbreviated to P1) using the GFP
fusion construct as a template (Figure 1C, left panel), and
the subcellular localization was analyzed using confocal
laser scanning microscopy as shown in the right panel
of Figure 1C. With the deletion of the NLS, P1-WD40
(1–285aa) and P1-dNLS (deltaNLS, 1–368 aa), the
GFP fusion proteins were excluded from the nuclei
(Figure 1C-1 and 2), suggesting that the predicted NLS
is essential for the nuclear localization of PAK1IP1.
Consistently, the GFP-putative NLS fusion proteins
were only detected in the nucleus and nucleolus
(Figure 1C-3 and 4). The ﬂanking sequence (286–368aa)
did not affect the nuclear localization of the fusion
protein, but it might play a regulatory role in nucleolar
localization of this protein, as deletion of the ﬂanking
sequence of NLS increased the ﬂuorescence intensity of
the GFP-fusion protein in nucleoplasm (comparing
Figure 1C-3 and 4). Further mutation analysis of each
(R/K) (R/K) X (R/K) motif indicated that each of the
motifs is important for the nucleolar localization of the
protein (Figure 1C-5–7). Mutation of each motif excluded
the protein from the nucleolus (Figure 1C-5–7). When the
frame-shifted NLS (369–392 aa) was fused with GFP, the
chimera protein was expressed in both nucleus and cyto-
plasm in all transfected cells (Figure 1B-8). These results
demonstrate that three (R/K) (R/K) X (R/K) motifs
within the C-terminal NLS/NoLS region of PAK1IP1
are essential for nucleolar and nuclear localization of the
protein and suggest that they may play a regulatory role in
PAK1IP1 cellular function.
Ectopic expression of PAK1IP1 inhibits cell proliferation
and colony formation in p53-containing, but not p53-
deﬁcient, cells
Since PAK1IP1 is induced by ribosomal stress, we
initiated our analysis by asking what the subsequent con-
sequence is when PAK1IP1 is overexpressed. A modiﬁed
lentiviral-based pLL3.7 vector system (37) was employed
for the overexpression of GFP-PAK1IP1 or its mutant
proteins. U2OS cells were infected with control, wild-
type and mutant PAK1IP1 lentiviruses, respectively. Cell
number was counted every day for 7 days post-infection
for analysis of cell growth (Figure 2A). The growth of the
cells infected with wild-type PAK1IP1 or P1-mNoLS
(nuclear localization excluded in nucleolus) was signiﬁ-
cantly inhibited in comparison with that of control and
P1-dNLS (cytoplasmic localization) infected cells. These
results suggest that high levels of PAK1IP1 suppress cell
proliferation. To conﬁrm the inhibitory effect of PAK1IP1
on cell proliferation, we carried out MTS and colony
formation assays in U2OS cells. As shown in Figure 2B
and C, wild-type PAK1IP1 and P1-mNoLS mutant dra-
matically inhibited cell viability and colony formation,
whereas vector-control and P1-dNLS mutant did not
show any effect. Of note, the inhibitory effect of wild-
type PAK1IP1 was stronger than that of the nuclear-
localized P1-mNoLS mutant. These results demonstrate
that ectopic overexpression of PAK1IP1 can inhibit cell
proliferation and that PAK1IP1-mediated inhibition relies
on its subcellular localization.
To determine whether the inhibition of cell proliferation
by PAK1IP1 has any relationship with p53, we examined
the effects of PAK1IP1 on p53-positive cells (HeLa, A549)
and p53-deﬁcient cells (Saos2 and H1299) using cell
proliferation and colony formation assays. As shown in
Figure 2D, overexpression of PAK1IP1 and P1-mNoLS
inhibited colony formation in p53-containing, but not
p53-deﬁcient, tumor cells. Similar data were obtained
with cell proliferation assays (data not shown). Taken
together, these results suggest that the inhibitory effect
of PAK1IP1 on cell proliferation and colony formation
is associated with the expression of p53.
Overexpression of PAK1IP1 leads to inhibition of DNA
synthesis and G1 phase arrest
To gain more insights into the PAK1IP1 inhibition of cell
proliferation, we conducted 5-bromodeoxyuridine (BrdU)
incorporation assays. Overexpression of PAK1IP1 and
P1-mNoLS, but not PAK1IP1-dNLS, signiﬁcantly
reduced the number of BrdU positive cells (Figure 3A),
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Figure 1. PAK1IP1 is a nucleolar stress induced protein with nuclear localization. (A) Nucleolar stress induces PAK1IP1 expression. HeLa cells were
treated with increasing doses of 5-FU and ActD as indicated for 18h. Cell lysates were assayed for the expression of PAK1IP1 and p53 by western
blot. (B) Subcellular localization analysis of PAK1IP1. (B-1) Endogenous PAK1IP1 colocalizes with NPM in the nucleus and accumulates in the
nucleolus. Immunostaining of HeLa cells was performed with anti-PAK1IP1 (green) and anti-NPM1 (red) antibodies. The nuclei were stained with
DAPI. (B-2) GFP-PAK1IP1 recombinant protein colocalizes with NPM in the nucleus and accumulates in the nucleolus. HeLa cells were
co-transfected with GFP-PAK1IP1 and ﬂag-NPM. Twenty-four hours post-transfection, the cells were immunostained with anti-ﬂag antibody
and DAPI. (C) Subcellular localization analysis of PAK1IP1 mutants. HeLa cells were transfected with different PAK1IP1 mutants, respectively.
After 24h, cells were ﬁxed and examined under confocal laser scanning microscopy. 1, GFP-PAK1IP1-WD40; 2, GFP-PAK1IP1-dNLS; 3,
GFP-PAK1IP1-dWD40; 4, GFP-PAK1IP1-NLS; 5, GFP-PAK1IP1-mNoLS1; 6 GFP-PAK1IP1-mNoLS2; 7, GFP-PAK1IP1-mNoLS3; 8,
GFP-fsNLS. P1, PAK1IP1; d, delta; m, mutant; fs, frame-shift. Diagram of each transfected construct was presented on the left panel. Bars, 20mm.
2238 Nucleic Acids Research, 2011,Vol.39, No. 6suggesting that PAK1IP1 indeed inhibits cell proliferation
via reduction of DNA synthesis.
To determine the effect of PAK1IP1 on cell-cycle pro-
gression, we performed cell-cycle analysis of cells infected
with vector control or PAK1IP1 using FACS analysis in
U2OS cells. As shown in Figure 3B, signiﬁcantly more cells
that expressed GFP-PAK1IP1 were accumulated at G1
phase than that expressing GFP vector control ( 67%
over  47%) (Figure 3B-1, left panel). Correspondingly,
the percentage of cells in S phase was reduced in
PAK1IP1 infected cells (27%) compared with that in the
control cells (45%). To determine whether the cell-cycle
A
C
D
B
Figure 2. Overexpression of PAK1IP1 inhibits cell proliferation. (A) PAK1IP1 inhibits the U2OS cell proliferation. A total of 1.5 10
4 infected cells
were seeded in 24-well plate, and grown for 1–7 days and the cell number was counted every day. (B) PAK1IP1 reduces the number of viable U2OS
cells. Equal numbers of cells infected with different constructs were seeded in multiples in 96-well plate. After 72h, the plate was subjected to the
MTS assay. (C) Overexpression of PAK1IP1 inhibits colony formation. Equal numbers of infected U2OS cells were seeded into 33-mm dishes. After
a period of 14 days, the cells were stained with crystal violet. The average numbers of colonies were shown in (C-2). (D) Overexpression of PAK1IP1
inhibits colony formation selectively in p53 positive cells. HeLa (p53 positive), Saos2 (p53 null), A549 (p53 positive) and H1299 (p53 null) were
infected with lentivirus and seeded into 33-mm dishes as described in ‘Materials and Methods’ section. The average numbers of colonies were shown
compared to vector control. P1: PAK1IP1. n=3, **P<0.01 and *P<0.05 compared to control.
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Figure 3. Overexpression of PAK1IP1 inhibits BrdU incorporation and induces G1/S cell-cycle delay. (A) Overexpression of PAK1IP1 inhibits BrdU
incorporation. HeLa cells were transfected with control, PAK1IP1, P1-mNoLS or P1-dNLS, respectively. The cells were immunostained with BrdU
speciﬁc antibody (A-1). The percentages of BrdU positive cells in GFP labeled population (A-2) were determined as described in ‘Materials and
Methods’ section. The arrows showed the GFP-positive cells with much less BrdU incorporation, and the data were from three independent
experiments. (B) Overexpression of PAK1IP1 induces G1/S cell-cycle delay. (B-1), U2OS cells were transfected with or without p53 siRNA respect-
ively, after 12h, the cells were infected with lentivirus of PAK1IP1 and control vector, then the cells were analyzed by FACS analysis. (B-2),
overexpression of PAK1IP1 regulates G1/S phase transition in synchronized cells. The post-infected cells were synchronized with double-thymidine
block, and then the cells were collected at the indicated time points after release. Cell-cycle distributions of the cells were analyzed by FACS analysis.
The error bars indicate standard deviations from three independent experiments, and the differences in both variables were analyzed for signiﬁcance
by Student’s t-test. P1, PAK1IP1. Thy, thymidine. **P<0.01 and *P<0.05. Bars, 20mm.
2240 Nucleic Acids Research, 2011,Vol.39, No. 6delay by PAK1IP1 is dependent on p53, U2OS cells
were infected with vector or PAK1IP1 after knocking
down of p53 by siRNA (Supplementary Figure S2D).
Through FACS analysis, the siRNA-mediated silencing
of p53 signiﬁcantly reduced PAK1IP1 induced G1 arrest
(Figure 3B-1, right panel). Consistent with the result in
Figure 2D, overexpression of PAK1IP1 did not affect
cell-cycle progression in p53-deﬁcient H1299 cells (data
not shown) either, indicating that these effects of
PAK1IP1 are p53-dependent.
To further analyze cell-cycle progression in PAK1IP1
overexpressed cells, the infected U2OS cells were
synchronized with double thymidine treatment, and har-
vested at different time points after withdrawing thymi-
dine in the culture medium. PAK1IP1 infected and control
cells exhibited similar cell-cycle distribution after thymi-
dine treatment, indicating equally synchronized efﬁciency
of the cells (Figure 3B-2, time 0). However, cells trans-
fected with PAK1IP1 were accumulated at G1 phase
more signiﬁcantly, particularly at the 4-h time point, in
comparison with the control cells (Figure 3B-2, 4h).
Similar results were also obtained in HeLa cells but not
in p53-deﬁcient H1299 cells (data not shown). These
results demonstrate that ectopic overexpression of
PAK1IP1 induces p53-dependent G1 delay.
Overexpression of PAK1IP1 leads to the increase of p53
level and activity
To determine whether PAK1IP1 induces p53-dependent
G1 arrest by affecting p53 level and activity, we
analyzed p53 levels after overexpression of PAK1IP1 by
immunoﬂuorescence staining and western blot analysis in
U2OS cells. Overexpression of PAK1IP1 or P1-mNoLS,
but not the P1-dNLS, led to p53 accumulation in the
nuclei using GFP ﬂuorescence and speciﬁc anti-p53
antibody (Figure 4A, arrows). Furthermore, PAK1IP1
increased the protein expression levels of p53, MDM2,
and p21 using western blot analysis (Figure 4B). By
contrast, the cytoplasmic mutant of PAK1IP1 failed to
induce p53 and its target proteins (Figure 4A and B). To
investigate how PAK1IP1 induces p53 levels, we further
examined the half-life of p53 in PAK1IP1 or vector
infected U2OS cells by western blot analysis. As shown
in Figure 4C, the half-life of the p53 protein was signiﬁ-
cantly extended to >4h in PAK1IP1 infected cells from
half an hour in control cells (Figure 4C), suggesting that
overexpression of PAK1IP1 can lead to p53 stabilization.
PAK1IP1 associates with MDM2 and inhibits
MDM2-mediated p53 ubiquitination and degradation
To gain further insight into the mechanisms underlying
the stabilization of p53, we sought to test whether
PAK1IP1 interacts with MDM2, because the stability of
p53 is tightly controlled by MDM2 (8,9,42). To determine
whether exogenous PAK1IP1 and MDM2 can interact
with each other, we co-transfected 293T cells with Flag-
PAK1IP1 and pcDNA3-MDM2, followed by co-IP-IB
assays. As shown in Figure 5A, MDM2 was speciﬁc-
ally co-immunoprecipitated with PAK1IP1 by the
anti-Flag antibody in cells co-transfected with both
pcDNA3-MDM2 and Flag-PAK1IP1. Conversely,
PAK1IP1 was speciﬁcally co-immunoprecipitated with
MDM2bytheanti-MDM2 antibody incells co-transfected
with pcDNA3-MDM2. These results suggest that over-
expressed PAK1IP1 associates with MDM2. To conﬁrm
whether endogenous PAK1IP1 and MDM2 also asso-
ciate with each other, we conducted immunoprecipiation
assays in U2OS cells. As shown in the representative
Figure 5B, endogenous PAK1IP1 and MDM2 were
co-immunoprecipitated by anti-MDM2 or anti-PAK1IP1
antibodiesrespectively,butnotIgG(Figure5B).Tofurther
determinetheassociationofPAK1IP1withMDM2,U2OS
cells were co-transfected with GFP-PAK1IP1 and Flag-
MDM2, followed by immunoﬂuorescence staining using
anti-Flag antibodies. As shown in Figure 5C, ectopic
MDM2 was expressed primarily in the nucleoplasm,
while GFP-PAK1IP1 was expressed in the whole nuclear
but predominantly in the nucleolus. Confocal microscopy
indicates that the subcellular distribution patterns of
PAK1IP1 and MDM2 are compatible with their inter-
action in the nucleoplasm. To investigate if the association
affects MDM2-mediated p53 ubiquitylation and degrad-
ation, co-transfection and ubiquitination assays were
performed in p53-deﬁcient H1299 cells to avoid the inter-
ferenceofendogenousp53protein.Asshown inFigure 5D,
when exogenous proteins were introduced into H1299
cells, nuclear PAK1IP1, but not the cytoplasmic mutant
(dNLS), inhibited MDM2 mediated p53 degradation.
Overexpression of PAK1IP1 as well as its nucleus-localized
mutant, but not cytoplasm-localized mutant, also inhibited
MDM2-mediated p53 ubiquitination (Figure 5E). These
results indicate that PAK1IP1 can stabilize p53 by inhibit-
ing MDM2-mediated p53 ubiquitination and degradation,
and the nuclear localization of PAK1IP1 is critical for this
inhibition.
Knockdown of PAK1IP1 inhibits cell proliferation and
induces cell-cycle delay
To determine the physiological relevance of PAK1IP1 in
the regulation of the cell proliferation, we employed a
lentiviral based RNA interference system using two differ-
ent shRNA for PAK1IP1. Both the mRNA and protein
levels of endogenous PAK1IP1 were efﬁciently ablated
when shRNA2 was introduced into the cells while
shRNA1 has no effect on the level of PAK1IP1
(Supplementary Figure S2A–C). Surprisingly, knockdown
of endogenous PAK1IP1 also inhibited cell proliferation
by cell growth and MTS assays in HeLa cells (Figure 6A
and B). Since overexpression of PAK1IP1 inhibited cell
proliferation in a p53-dependent manner, we next tested
whether the inhibition of cell proliferation by knocking
down PAK1IP1 is also p53 dependent. As shown in
Figure 6C, knockdown of PAK1IP1 inhibited prolifer-
ation of p53-deﬁcient H1299 cells by  30%. To further
conﬁrm the data, colony formation assays were performed
in p53-proﬁcient (HeLa, U2OS, A549) and p53–deﬁcient
(Saos2 and H1299) cells after knockdown of endogenous
PAK1IP1 by RNA interference. As shown in Figure 6D,
knockdown of PAK1IP1 in all ﬁve cell lines led to
inhibition of cell proliferation and colony formation.
Nucleic Acids Research,2011, Vol.39, No. 6 2241However, this inhibition was more apparent in p53-
proﬁcient cells than in p53-deﬁcient cells, suggesting that
knockdown of PAK1IP1 may also induce p53-dependent
cell growth arrest. These results indicate that PAK1IP1 is
essential for cell proliferation while also plays a role in p53
response to nucleolar stress since both the up- or down-
regulation of PAK1IP1 leads to p53-dependent cell
growth arrest.
To determine whether knockdown of PAK1IP1 is
associated with the regulation of the MDM2-p53
pathway, we examined p53 levels using immunoﬂuores-
cence staining and western blot analysis. As shown in
Figure 6E and F, knockdown of endogenous PAK1IP1
led to p53 accumulation in the nuclei (Figure 6E) as well
as the increase of p21 and MDM2 levels (Figure 6F).
Furthermore, knockdown of PAK1IP1 drastically
AB
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Figure 4. PAK1IP1 induces the accumulation of tumor suppressor p53. (A) PAK1IP1 upregulates p53. U2OS cells were transfected with PAK1IP1,
P1-mNoLS or P1-dNLS GFP fusion constructs respectivly. The arrows showed GFP-positive cells that have more p53 protein. (B) Overexpression of
PAK1IP1 regulates p53 downstream target proteins. Different PAK1IP1 constructs as indicated were transfected into U2OS cells. Whole cell lysates
were harvested and separated by 10% SDS–PAGE for western blot analysis using antibodies speciﬁc for p53, p21, MDM2 and b-actin. (C) PAK1IP1
stabilizes p53. U2OS cells were infected with control vector or PAK1IP1 lentivirus for 48h and then cycloheximide (CHX) was supplemented into the
media (concentration of 50mg/ml). (C-1), the cells were harvested at indicated time points and subjected to western blot analysis with antibodies
speciﬁc for p53 and b-actin (C-1). (C-2), the bands were quantiﬁed and normalized with loading controls determined by b-actin expression in U2OS
(C-2). Bars, 20mm.
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Figure 5. PAK1IP1 associates with MDM2 and inhibits MDM2-mediated p53 ubiquitylation and degradation. (A) Ectopically expressed PAK1IP1
interacts with ectopically expressed MDM2 in 293T cells. Cells were transfected with Flag-PAK1IP1 and pcDNA3-MDM2 individually or together.
Cell lysates were immunoprecipitated with anti-Flag or anti-MDM2 antibodies, followed by IB with anti-Flag or anti-MDM2 antibodies.
(B) Endogenous PAK1IP1 interacts with endogenous MDM2 in U2OS cells. Cell lysates were immunoprecipitated with anti-PAK1IP1 polyclonal
antibodies or rabbit immunoglobulin G (IgG), anti-MDM2 antibodies, or IgG, followed by anti-PAK1IP1 and anti-MDM2 antibodies, respectively.
(C) PAK1IP1 colocalizes with MDM2 in the nucleus. U2OS cells were co-transfected with GFP-PAK1IP1 and Flag-MDM2. The cells were observed
with a confocal laser scanning microscopy for GFP (green) or were immunostained with anti-Flag antibody, followed by staining with goat
anti-rabbit secondary antibody (red) and DAPI. (D) PAK1IP1 inhibits MDM2-mediated p53 degradation. H1299 cells were transfected with the
combinations of plasmids as indicated. Cell lysates were subjected to immunoblot using antibodies as indicated. (E) PAK1IP1 inhibits
MDM2-mediated p53 ubiquitylation. H1299 cells were transfected with the combinations of indicated plasmids. The transfected cells were treated
with MG132 (20mM) for 6h before harvest. Total p53 and ubiquitylated proteins p53 [p53-(ub)n] were detected by immunobloting with speciﬁc
anti-p53 antibody (upper panel). Ubiquitylated was indicated. The expression of total p53, MDM2, and PAK1IP1 proteins were shown in the lower
panels. Bars, 10mm.
Nucleic Acids Research,2011, Vol.39, No. 6 2243AB
D C
E
GH
F
Figure 6. Knockdown of PAK1IP1 inhibits cell proliferation with p53 activation. (A, B and C) Knockdown of PAK1IP1 inhibits cell growth and
viability. Cell growth curves of HeLa (A) and H1299 (C) cells, infected with the indicated lentivirus, were determined from Day 1 to Day 7 after
infections. The same number of infected cells was seeded in 24-well plates to grow for 1–7 days and the cell number was counted every day. The
number of viable cells in HeLa cells was measured by MTS (B). (D) Knockdown of PAK1IP1 reduces the efﬁciency of colony formation in p53
positive and negative cells. Indicated cells were infected with scramble or PAK1IP1 shRNA lentiviruses (shRNA1 or shRNA2) and seeded into
33-mm dish with 1000 cells. After a 14-day growth, the numbers of colonies were counted as described in ‘Materials and Methods’ section. Data was
representative of three independent experiments (n=3),
*P<0.05,
**P<0.01 compared to scramble RNA-infected cells. (E) Knockdown of
PAK1IP1 upregulates p53 protein level. HeLa cells were infected with indicated lentiviruses for 48h. GFP and p53 were detected by immunostaining
with confocal laser scanning microscopy. The arrows showed that the p53 protein was accumulated in GFP-positive cells indicating the knockdown
of PAK1IP1. (F) Down-regulation of PAK1IP1 increased protein level of p53 and its target proteins, MDM2 and p21. (G) Knockdown of PAK1IP1
induces G1/S cell-cycle delay. HeLa cells were infected with the indicated lentiviruses for 48h. Cell-cycle distributions were analyzed by FACS
analysis. (H) Knockdown of PAK1IP1 inhibits BrdU incorporation. HeLa cells were transfected with the indicated plasmids for 48h and then BrdU
was supplemented. After 10h, the cells were immunostained with BrdU speciﬁc antibody (red) and the nucleus was stained with DAPI. The arrows
showed the GFP-positive cells with undetectable BrdU incorporation. Bars, 20mm.
2244 Nucleic Acids Research, 2011,Vol.39, No. 6induced cell-cycle arrest in the G1 phase (Figure 6G), and
inhibited DNA synthesis in HeLa cells as determined by
BrdU incorporation assays (Figure 6H). These results
indicate that the depletion of PAK1IP1 also induces p53
activation and G1 arrest.
Knockdown of PAK1IP1 increases the free ribosomal
proteins and enhances the interaction of MDM2 with
RPL5 and RPL11
The functional inactivation of yeast PAK1IP1 homolog
Mak11 and Skb15 impaired the rRNA synthesis, and led
to a cell-cycle delay in G1 (31). As we know that inhibition
of rRNA synthesis leads to disassembly of ribosomal pre-
cursors and release of ribosome-unbound ribosomal
proteins from the nucleolus (43). Since PAK1IP1 is a evo-
lutionarily conserved protein, we hypothesize that
knockdown of PAK1IP1 may lead to the release of ribo-
somal proteins which then activates p53. To conﬁrm the
role of PAK1IP1 in ribosomal protein release, we carried
out a sucrose gradient fractionation assay to separate
soluble proteins from ribosomal monosomes/polysomes
in scramble- and PAK1IP1- shRNA infected HeLa cells.
The collected fractions were analyzed for L5 and L11
proteins by western blotting. Notably, the levels of L5
and L11 in the soluble, ribosome-unbound fractions
were evidently increased in PAK1IP1-depleted cells,
indicating that L5 and L11 were released from the riboso-
mal subunits as ribosome free, proteins in the cell lysates
(Figure 7A), but the total level of these two ribosomal
proteins was not affected (Figure 7C, lysate).
Since the protein level of PAK1IP1 was induced when
the cells were treated with either actinomycin D or 5-FU
(Figure 1A), we suspect that PAK1IP1 is an integrated
component of the nucleolus and that depletion of
PAK1IP1 could trigger a nucleolar stress that activates
p53. Nucleolar stress usually leads to the disruption of
the nucleolus (44), so we ﬁrst examined the nucleolar
structure upon the PAK1IP1 knockdown by using
immune-ﬂuorescence staining. Surprisingly, as determined
by the nucleolar marker NPM1, knockdown of PAK1IP1
did not signiﬁcantly alter the nucleolar structure
(Figure 7B). Since the free L5 and L11 were increased in
PAK1IP1 knockdown cells, we determined whether
knockdown of PAK1IP1 by shRNA could activate the
ribosomal protein–MDM2–p53 pathway by examining
the interaction of L5 and L11 with MDM2, respectively.
HeLa cells infected with scrambled or PAK1IP1 shRNA
were analyzed by co-IP assays with anti-MDM2
antibodies. As shown in Figure 7C, knockdown of
PAK1IP1 indeed enhanced the interaction between
MDM2 and L5 or L11 but did not change the protein
levels of these two ribosomal proteins. These results
suggest that the interaction between MDM2 and riboso-
mal proteins (L5 or L11) is also responsive to the deple-
tion of PAK1IP1 by RNA interference.
Knockdown of L5 or L11 attenuates PAK1IP1
depletion-induced p53 activation
The enhanced interaction of MDM2 with L5 and L11
suggests that these ribosomal proteins may play a role in
PAK1IP1 knockdown induced p53 activation. To conﬁrm
the role of ribosomal proteins in PAK1IP1 depletion-
induced p53 activation, the expression of L5 or L11 was
depletedbysiRNAs inPAK1IP1-deﬁcit or controlcells. As
shown in Figure 7, reduction of either L5 (Figure 7D) or
L11 (Figure 7E) protein by siRNAs markedly inhibited
the PAK1IP1 knockdown-induced p53 levels in com-
parison with that of the scrambled RNA-transfected cells.
Consistently, the induction of MDM2 and p21 protein
levels by the PAK1IP1 knockdown was drastically
reduced by shRNAs against L5 or L11 but not by the
scrambled sequences (Figure 7D and E). This reduction
of MDM2 and p21 was also observed in mRNA levels
as measured by real-time-PCR assays (Supplementary
Figure S3). Together, these results demonstrate that the
ribosomal protein–MDM2–p53 pathway play a critical
role in PAK1IP1 knockdown-caused p53 activation.
DISCUSSION
We previously showed that PAK1IP1 is a WD-repeat con-
taining protein, which interacts with PAK1 and inhibits its
kinase activity. A null mutation of the ﬁssion yeast
ortholog, Skb15, is lethal and results in the deregulation
of actin polymerization, microtubule biogenesis, and cell-
cycle arrest (29). However, the physiological function of
this evolutionarily conserved protein remains obscure. In
the current study, we show that PAK1IP1 is mainly
localized in the nucleolus with some in the nucleus. In
addition, we identiﬁed the NLS and NoLs sequences in
the C-terminus of PAK1IP1, which are essential for the
subcellular localization of this protein. The protein level of
PAK1IP1 was induced when cells were treated with nucle-
olar stress-inducing agents. Interestingly, PAK1IP1 was
associated with MDM2 and reduced MDM2-mediated
p53 ubiquitination and degradation. Knockdown of en-
dogenous PAK1IP1 induces free ribosomal proteins (L5
and L11) which interact with MDM2 and activate p53
pathway. Together, either overexpression or knockdown
of PAK1IP1 in human cancer cells induced G1 arrest and
inhibited cell proliferation via a p53-dependent pathway.
The subcellular localization of PAK1IP1 is dependent
on three essential tandem KKXK motifs. The nuclear or
nucleolar localization of this protein appears to be crucial
for the function to block cell proliferation, as its
cytoplasm-localized mutant had no such function.
Furthermore, since the inhibitory effect of the nucleus-
localized mutant on cell proliferation was not as severe
as that of wild-type, this suggests that both nucleoplasmic
and nucleolar fractions of PAK1IP1 play an important
role in regulation of cell proliferation. It has been
reported that the Mak11 protein, the budding yeast
ortholog of PAK1IP1, is necessary for the maintenance
of killer M1 double-stranded RNA and the C-terminal
lysine-rich region is essential for Mak11-complementing
activity (28). The identiﬁcation of the NLS/NoLS in
PAK1IP1 in the current study explains why the
C-terminus is essential for Mak11 function. Since the
subcellular localization of PAK1IP1 is very important
for its function, it is very interesting to further study
Nucleic Acids Research,2011, Vol.39, No. 6 2245whether the subcellular localization of PAK1IP1 is
regulated by extracellular stimuli and the mechanism
through which the translocation of PAK1IP1 is regulated.
Malfunction of the rRNA biogenesis machinery causes
ribosomal stress and induces cell-cycle arrest, apoptosis or
senescence (25). Over the past ten years, numerous nucle-
olar proteins (ARF, NS, Bop1) or ribosomal proteins (L5,
L11, L23) have been identiﬁed to regulate cell prolifer-
ation through the MDM2-p53 feedback loop in response
to nucleolar stress (16,17,21,38,45,46). Although there is
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Figure 7. Knockdown of PAK1IP1 increases the free ribosomal proteins and enhances the interaction of MDM2 with RPL5 and RPL11.
(A) Polysome proﬁles from scramble (left panel) or PAK1IP1 shRNA (right panel) infected HeLa cells are shown. The fractions were precipitated
with 20% TCA, and the precipitated proteins were analyzed by western blotting. (B) Knockdown of endogenous PAK1IP1 does not disrupt the
nucleolus structure. HeLa cells were transfected with scramble or PAK1IP1 shRNA as indicated. The cells were then stained with anti-NPM1 (red)
antibodies and nucleus was stained with DAPI. (C) Knockdown of endogenous PAK1IP1 enhances the interaction of MDM2 with ribosomal
proteins, RPL5 and RPL11. HeLa cells were infected with the indicated lentiviruses. The same number of cells (scramble and shRNA) was lysated
and 5% were loaded as input control. To equal the total amount of MDM2 protein, all of the scramble cell lysates and 30% shRNA treated
cell lysates were subjected to IP using anti-MDM2 antibody, followed by IB to detect the protein levels of L11, L5 and MDM2, respectively.
(D and E) The knockdown of L5 or L11 abolishes the induction of p53 by the knockdown of PAK1IP1. HeLa cells were infected with
PAK1IP1-shRNA lentiviruses for 24h, and then transfected with scrambled siRNA, L5 siRNA (D), or L11 siRNA (E) as indicated. Cell lysates
were subjected to IB to detect the expression of p53, MDM2, p21, L5, or L11, as indicated. The knockdown efﬁciency of L5 and L11 protein
compared to actin was: L5-1(1.0), L5-2(1.2), L5-3(0.19), L5-4(0.15), and L11-1(1.0), L11-2 (1.05), L11-3(0.15), L11-4 (0.13). P1, PAK1IP1. Bars,
20mm.
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was reported that its orthologs, Mak11 and Skb15, act as
a cofactor of ribosomal protein Rlp24 and regulate 60S
rRNA maturation (31). We observed that the protein level
of PAK1IP1 was increased by ribosomal stress caused by
5-FU and ActD treatment (Figure 1A). This observation
led us to illustrate how PAK1IP1 responded to ribosomal
stress and regulated cell proliferation. It is possible that
ribosomal malfunction induced PAK1IP1 accumulation
and the superﬂuous of PAK1IP1 associates with MDM2
to induce p53 level and activity by inhibiting
MDM2-mediated p53 ubiquitination and degradation.
PAK1IP1 inhibits cell proliferation is dependent on p53
which is observed in several cell lines including HeLa cells.
However, the main p53 regulator in HeLa cell is HPV E6,
which causes its ubiquitylation irrespective of MDM2
(47,48). It remains unclear whether PAK1IP1 also modu-
lates HPV E6 activity.
In addition, we found that not only abnormally high
level, but also aberrant low level, of PAK1IP1 can induce
G1 arrest and inhibit cell proliferation. Our results support
the idea that aberrantly high levels of PAK1IP1 can
activate p53 by inhibiting MDM2 function. Furthermore,
we also found that aberrantly low levels of PAK1IP1 could
also induce p53 response probably by causing nucleolar
or ribosomal stress. In past years, the nucleolar proteins
havebeenshowntobecriticalfor60Sribosomematuration
(49–52). Such as the case for nucleostemin, whose level is
critically balanced and any off-balance would trigger p53
response (21). In cells, the pre-ribosomal RNA tran-
scripts are processed and modiﬁed by small nucleolar
ribonucleoproteins (snoRNPs). The modiﬁed rRNAs asso-
ciate with ribonucleoprotein and assembly with ribosomal
proteins to form 40S and 60S ribosome subunits which are
both exported to the cytoplasm where they bind to mRNA
to form functional 80S ribosome for protein translation
(22). Our unpublished data reveals that PAK1IP1 deple-
tion by shRNA impaired 28S rRNA processing and leads
to reduction of 60S ribosome subunits (data not shown).
Furthermore, the depletion of endogenous PAK1IP1
increases the ribosome-unbound form of L5 and L11,
and enhances their interactions with MDM2 (Figure 7C).
These ribosomal proteins are associated with ribosomal
biogenesis and required for nucleolar stress-induced p53
activation and cell-cycle arrest (21,53,54). The reason
why knockdown of PAK1IP1 mildly inhibits cell prolif-
eration of p53-deﬁcient cells remains unclear. It is likely
that the ribosomal stress induced by disruption of
PAK1IP1 expression causes a p53-independent pathway
which inhibits cell proliferation. In summary, our study
not only identiﬁes PAK1IP1 as a new regulator of the
p53–MDM2 pathway potentially in response to nucleolar
stress,butalsorevealsthattheadequatelevelofthisprotein
in cells is crucially important for maintaining cell growth
and proliferation.
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